PKSI 527
PKSI 527 Basic information
- Product Name:
- PKSI 527
- Synonyms:
-
- 2-[4-[[(2S)-2-[[4-(aminomethyl)cyclohexanecarbonyl]amino]-3-phenylpropanoyl]amino]phenyl]aceticacid,hydrochloride
- PKSI 527,PKSI527
- 2-(4-((S)-2-(trans-4-(Aminomethyl)cyclohexane-1-carboxamido)-3-phenylpropanamido)phenyl)acetic acid hydrochloride
- Benzeneacetic acid, 4-[[(2S)-2-[[[trans-4-(aminomethyl)cyclohexyl]carbonyl]amino]-1-oxo-3-phenylpropyl]amino]-, hydrochloride (1:1)
- CAS:
- 128837-71-8
- MF:
- C25H31N3O4.ClH
- MW:
- 473.998
- Mol File:
- 128837-71-8.mol
PKSI 527 Chemical Properties
- storage temp.
- -20°C
- solubility
- Soluble in Water (5 mg/ml)
- form
- White solid.
- color
- White
- Stability:
- Stable for 1 year from date of purchase as supplied. Solutions in water may be stored at -20°C for up to 3 months.
PKSI 527 Usage And Synthesis
Description
PKSI-527 (128837-71-8) is a selective plasma kallikrein inhibitor (Ki = 0.81 μM)1 that can be used for affinity purification of kallikrein2.? Synergizes with NO donors to produce antithrombic effects ex-vivo.3? Suppresses collagen-induced arthritis in mouse models.4
References
Wanaka et al. (1992), Synthesis of trans-4-aminomethylcyclohexanecarbonyl-L- and –D-phenylalanine-4-carboxymethylanilide and examination of their inhibitory activity against plasma kallikrein;? ?Chem. Pharm. Bull., 40 1814 Tada et al. (2001), Isolation of plasma kallikrein by high efficiency affinity chromatography and its characterization; Chem. Pharm. Bull., 24 520 Ikarugi et al. (2005), Synergistic antithrombotic effect of a combination of NO donor and plasma kallikrein inhibitor; Thromb. Res., 116 403 Fujimori et al. (1993), Effects of a highly selective plasma kallikrein inhibitor on collagen-induced arthritis in mice; Agents Actions, 39 42
PKSI 527Supplier
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 400-9205774
- sales@glpbio.cn
- Tel
- 18818260767
- sales@chemegen.com
- Tel
- 400-1647117 13681763483
- product02@bidepharm.com
- Tel
- 021-57520305 15221441005
- wangkang@jskchem.com